Alignment Healthcare $132.75 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Roivant Sciences $400 million at-the-market offering
We advised the company on an SEC-registered at-the-market offering
IDEAYA Biosciences $92 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Alnylam Pharmaceuticals $1.035 billion convertible senior notes offering
The 1% convertible notes are due 2027
Immunocore $250 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
Biocytogen HK$549 million IPO
We advised Biocytogen on its IPO and HKEX listing
Assertio $70 million convertible senior notes offering
The 6.5% notes are due 2027
Oak Street Health $180.3 million secondary offering
We advised the joint book-running managers on the equity offering
Tenaya Therapeutics $75 million at-the-market offering
The common stock is listed on the Nasdaq Global Select Market
ADC Therapeutics $175 million term loan facility and other financings
We advised the company on the new facility, a $115 million exchange and a $6.25 million share sale